Search for notes by fellow students, in your own course and all over the country.
Browse our notes for titles which look like what you need, you can preview any of the notes via a sample of the contents. After you're happy these are the notes you're after simply pop them into your shopping cart.
Title: Weber, Leonard J.. Profits before People? : Ethical Standards and the Marketing of Prescription Drugs, Indiana University Press, 2006.
Description: Weber, Leonard J.. Profits before People? : Ethical Standards and the Marketing of Prescription Drugs, Indiana University Press, 2006.
Description: Weber, Leonard J.. Profits before People? : Ethical Standards and the Marketing of Prescription Drugs, Indiana University Press, 2006.
Document Preview
Extracts from the notes are below, to see the PDF you'll receive please use the links above
“It has all gone terribly wrong for the dozen or so manufactures that make up “big pharma””statement that introduced a review of pharmaceutical industry’s problem in a March 2005
article in The Economist (look for reference 1)
...
They stand accused of focusing on “me-too” drugs which confer little clinical benefit
over existing medicines; rushing these to market through cunning clinical trials
designed to make them look better than they are ; and suppressing data to the
contrary
...
(look for reference 2)
When the pharmaceutical company Merck announced in the fall of 2004 that it was taking its
blockbuster pain drug Vioxx( rofecoxib) off the market because of evidence that its use
contributed to increased heart attacks or strokes, some gave Merck credit for taking that
action before it was mandated by the Food and Drug Administration (FDA)
...
There had been
earlier warning signs of the risks associated with the use of Vioxx and Merck’s response at
that time had been to market the medication aggressively
...
The FDA convened a panel of experts to advise on whether to permit the marketing of
Vioxx
...
“If the 10 advisors had not cast their vots, the committee would have voted 14
to 8 that Vioxx should not return the market” (look for reference 6)
Business ethics is not primarily about individual behaviour
...
Given the nature and impact of this particular industry and the potential
consequences of a particular marketing-related practice, does this practice reflect high
ethical standards?
David Blumenthal : “As a for-profit business, the pharmaceutical industry should be
expected to market its products aggressively within legal boundaries
...
Instead it
has become common in recent years for business executives to make the claim that “good
ethics is good business”
...
In order to understand its marketing responsibilities, it is essential to emphasize that the
pharmaceutical industry manufactures and sells prescription drugs, not some other product
...
In the case of a typical consumer product,
consumers themselves make the decisions about whether to use the product
...
Relman and Angell are right on target: “the misconception that drugs and their market are
like other goods and markets explains most of the serious problems with the pharmaceutical
industry today
Title: Weber, Leonard J.. Profits before People? : Ethical Standards and the Marketing of Prescription Drugs, Indiana University Press, 2006.
Description: Weber, Leonard J.. Profits before People? : Ethical Standards and the Marketing of Prescription Drugs, Indiana University Press, 2006.
Description: Weber, Leonard J.. Profits before People? : Ethical Standards and the Marketing of Prescription Drugs, Indiana University Press, 2006.